 |
 |

Vitiligo and SympathectomyThe Effect of Sympathectomy and -Melanocyte Stimulating Hormone
AARON B. LERNER, MD;
RICHARD S. SNELL, MD;
M. L. CHANCO-TURNER, MD;
JOSEPH S. McGUIRE, MD
Arch Dermatol. 1966;94(3):269-278.
Abstract
A 29-year-old man with vitiligo was treated by sympathectomy and later by racemized -melanin-stimulating hormone (MSH). Only a slight increase in melanogenic activity of normal skin followed sympathectomy, while the vitiligo progressed. Alpha-MSH produced darkening and melanocytic activity in normal skin, but vitiliginous areas were unaffected.
Author Affiliations
NEW HAVEN, CONN
From the Section of Dermatology, Department of Medicine, and the Department of Anatomy, Yale University School of Medicine, New Haven, Conn.
Footnotes
Accepted for publication March 4, 1966.
Reprint requests to Yale University School of Medicine, New Haven, Conn 06504 (Dr. Lerner).
CiteULike Connotea Del.icio.us Digg Facebook Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Vitiligo: Clinical Picture and Pathogenesis
McBurney
Arch Intern Med 1979;139:1295-1297.
ABSTRACT
|